Viewing Study NCT04473261


Ignite Creation Date: 2025-12-24 @ 11:50 AM
Ignite Modification Date: 2025-12-31 @ 2:21 PM
Study NCT ID: NCT04473261
Status: UNKNOWN
Last Update Posted: 2021-07-07
First Post: 2020-07-14
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Efficacy of Iodine Complex Against COVID-19 Patients
Sponsor: Sohaib Ashraf
Organization:

Study Overview

Official Title: Efficacy of Iodine Complex in Mild to Moderate COVID-19 Patients
Status: UNKNOWN
Status Verified Date: 2021-07
Last Known Status: RECRUITING
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: I-COVID-PK
Brief Summary: The objective of this study is to measure the effect of Iodine complex in treating the COVID-19 patients to clear viral load of SARS-CoV-2 along with reduction in severity of symptoms and length of hospitalization of patients with COVID-19.
Detailed Description: The proposed study is a placebo-controlled, add-on, randomized trial using parallel group designs. This is a close-label and adaptive, multi-centered design with 1:1:1:1 allocation ratio and superiority framework.

Study Oversight

Has Oversight DMC: True
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: